Pivotal role of ADAMTS13 function in liver diseases

International Journal of Hematology

Volumn 91, Issue 1, 2010, Pages 20-29

  Uemura, Masahito ^a   Fujimura, Yoshihiro ^a   Ko, Saiho ^a   Matsumoto, Masanori ^a   Nakajima, Yoshiyuki ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS13; Alcoholic hepatitis; Liver cirrhosis; Liver transplantation; Microcirculatory disturbance; Multiorgan failure; Veno occlusive disease; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ALCOHOL LIVER DISEASE; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; GRAFT VERSUS HOST REACTION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MICROCIRCULATION; REVIEW; SHEAR STRESS; STELLATE CELL; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM; VEIN OCCLUSION;

ADAM PROTEINS; HEPATIC STELLATE CELLS; HUMANS; LIVER DISEASES; MULTIPLE ORGAN FAILURE; THROMBOSIS;

EID: 75049085372     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0481-4     Document Type: Review

References (77)

1. JL Kujovich 2005 Hemostatic defects in end stage liver disease Crit Care Clin 21 563 587 10.1016/j.ccc.2005.03.002 15992673 (Pubitemid 40898159)
2. PG Northup V Sundaram MB Fallon KR Reddy RA Balogun AJ Sanyal, et al. 2008 Hypercoagulation and thrombophilia in liver disease J Thromb Haemost 6 2 9 1:STN:280:DC%2BD1c7gtF2nug%3D%3D 17892532
3. JL Moake 2002 Thrombotic microangiopathies N Engl J Med 347 589 599 10.1056/NEJMra020528 1:CAS:528:DC%2BD38Xmt1yit7Y%3D 12192020 (Pubitemid 34898873)
4. Y Fujimura M Matsumoto H Yagi A Yoshioka T Matsui K Titani 2002 Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome Int J Hematol 75 25 34 10.1007/BF02981975 1:CAS:528:DC%2BD38XitFOmu7w%3D 11843286
5. GG Levy WC Nichols EC Lian T Foroud JN McClintick BM McGee, et al. 2001 Mutations in a member of the ADAMTS13 gene family cause thrombotic thrombocytopenic purpura Nature 413 488 494 10.1038/35097008 1:CAS:528:DC%2BD3MXnsFyit70%3D 11586351 (Pubitemid 32938741)
6. K Kokame M Matsumoto K Soejima H Yagi H Ishizashi M Funato, et al. 2002 Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity Proc Natl Acad Sci USA 99 11902 11907 10.1073/pnas.172277399 1:CAS:528:DC%2BD38XntFWqtbw%3D 12181489 (Pubitemid 34994496)
7. M Furlan R Robles M Galbusera G Remuzzi PA Kyrle B Brenner, et al. 1998 von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N Engl J Med 339 1578 1584 10.1056/NEJM199811263392202 1:STN:280:DyaK1M%2Fjt1Sgsg%3D%3D 9828245 (Pubitemid 28536132)
8. HM Tsai EC Lian 1998 Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura N Engl J Med 339 1585 1594 10.1056/NEJM199811263392203 1:STN:280:DyaK1M%2Fjt1Sgsw%3D%3D 9828246 (Pubitemid 28536133)
9. M Matsumoto H Chisuwa Y Nakazawa T Ikegami Y Hashikura S Kawasaki, et al. 2000 Living-related liver transplantation rescues reduced vWF-cleaving protease activity in patients with cirrhotic biliary atresia Blood 96 636a (abstr.)
10. X Zheng D Chung TK Takayama EM Majerus JE Sadler K Fujikawa 2001 Structure of von Willebrand factor-cleaving protease (ADAMTS 13), metalloproteinase involved in thrombotic thrombocytopenic purpura J Biol Chem 276 41059 41063 10.1074/jbc.C100515200 1:CAS:528:DC%2BD3MXosVKgsLw%3D 11557746
11. K Soejima N Mimura M Hirashima H Maeda T Hamamoto T Nakagaki, et al. 2001 A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem 130 475 480 1:CAS:528:DC%2BD3MXovVCqtr0%3D 11574066
12. M Uemura K Tatsumi M Matsumoto M Fujimoto T Matsuyama M Ishikawa, et al. 2005 Localization of ADAMTS13 to the stellate cells of human liver Blood 106 922 924 10.1182/blood-2005-01-0152 1:CAS:528:DC%2BD2MXntVSnurc%3D 15855280 (Pubitemid 41076434)
13. M Suzuki M Murata Y Matsubara T Uchida H Ishihara T Shibano, et al. 2004 Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets Biochem Biophys Res Commun 313 212 216 10.1016/j.bbrc.2003.11.111 1:CAS:528:DC%2BD3sXps1ert7c%3D 14672719 (Pubitemid 37524045)
14. N Turner L Nolasco Z Tao JF Dong J Moake 2006 Human endothelial cells synthesize and release ADAMTS-13 J Thromb Haemost 4 1396 1404 10.1111/j.1538-7836.2006.01959.x 1:CAS:528:DC%2BD28XmsVGhtr4%3D 16706987 (Pubitemid 43756721)
15. M Manea A Kristoffersson R Schneppenheim MA Saleem PW Mathieson M Mörgelin, et al. 2007 Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura Br J Haematol 138 651 662 10.1111/j.1365-2141.2007.06694.x 1:CAS:528:DC%2BD2sXhtVKgsr%2FK 17627784 (Pubitemid 47206716)
16. Z Kmieć 2001 Cooperation of liver cells in health and disease Adv Anat Embryol Cell Biol 161 1 151
17. DC Rockey 2001 Hepatic blood flow regulation by stellate cells in normal and injured liver Semin Liver Dis 21 337 348 10.1055/s-2001-17551 1:STN:280:DC%2BD3MrjvFersg%3D%3D 11586464 (Pubitemid 32923764)
18. M Hattori Y Fukuda M Imoto Y Koyama I Nakano F Urano 1991 Histochemical properties of vascular and sinusoidal endothelial cells in liver diseases Gastroenterol Jpn 26 336 343 1:STN:280:DyaK3MzmsFWmsQ%3D%3D 1653746
19. F Schaffner H Popper 1963 Capillarization of hepatic sinusoids in man Gastroenterology 44 239 242 1:STN:280:DyaF387mvVCmsA%3D%3D 13976646
20. AK Davis RS Makar CP Stowell DJ Kuter WH Dzik 2009 ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13 Transfusion 49 206 213 10.1111/j.1537-2995.2008.01978.x 1:CAS:528:DC%2BD1MXjtVyis78%3D 19389207
21. PG Langley RD Hughes R Williams 1985 Increased factor VIII complex in fulminant hepatic failure Thromb Haemost 54 693 696 1:CAS:528:DyaL28XktF2j 3937267
22. L Albornoz D Alvarez JC Otaso A Gadano J Salviu S Gerona, et al. 1999 Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels J Hepatol 30 451 455 10.1016/S0168-8278(99)80104-4 1:STN:280:DyaK1M3gsFSjsQ%3D%3D 10190728 (Pubitemid 29113234)
23. D Ferro C Quintarelli A Lattuada R Leo M Alessandroni PM Mannucci, et al. 1996 High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia Hepatology 23 1377 1383 10.1002/hep.510230613 1:STN:280:DyaK283ktlWmtA%3D%3D 8675154
24. MO Rake PT Flute G Pannell R Williams 1970 Intravascular coagulation in acute hepatic necrosis Lancet 14 533 537 10.1016/S0140-6736(70)90767-1
25. T Knittel K Neubauer T Armbrust G Ramadori 1995 Expression of von Willebrand factor in normal and diseased rat livers and in cultivated liver cells Hepatology 21 470 476 1:CAS:528:DyaK2MXkt1Chtbc%3D 7531171
26. S Urashima M Tsutsumi K Nakase JS Wang A Takada 1993 Studies on capillarization of the hepatic sinusoids in alcoholic liver disease Alcohol Alcohol Suppl 1B 77 84 1:STN:280:DyaK2c3ntFemtQ%3D%3D 7516164
27. L Amitrano MA Guardascione V Brancaccio M Margaglione F Manguso L Iannaccone, et al. 2004 Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis J Hepatol 40 736 741 10.1016/j.jhep.2004.01.001 15094219 (Pubitemid 38507352)
28. IR Wanless F Wong LM Blendis P Greig EJ Heathcote G Levy 1995 Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension Hepatology 21 1238 1247 1:STN:280:DyaK2M3lsFOqsw%3D%3D 7737629
29. K Oka K Tanaka 1979 Intravascular coagulation in autopsy cases with liver diseases Thromb Haemost 42 564 570 1:STN:280:DyaL3c%2FlvFantQ%3D%3D 505365
30. K Kokame M Matsumoto Y Fujimura T Miyata 2004 VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13 Blood 103 607 612 10.1182/blood-2003-08-2861 1:CAS:528:DC%2BD2cXmsFChsg%3D%3D 14512308 (Pubitemid 38140094)
31. K Kokame Y Nobe Y Kokubo A Okayama T Miyata 2005 FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay Br J Haematol 129 93 100 10.1111/j.1365-2141.2005.05420.x 1:CAS:528:DC%2BD2MXktVCgtrg%3D 15801961 (Pubitemid 40524057)
32. SC Meyer I Sulzer B Lämmle JA Kremer Hovinga 2007 Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies J Thromb Haemost 5 866 867 10.1111/j.1538-7836.2007.02438.x 1:CAS:528: DC%2BD2sXltlWgtbs%3D 17408415 (Pubitemid 46563591)
33. S Kato M Matsumoto T Matsuyama A Isonishi H Hiura Y Fujimura 2006 Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity Transfusion 46 1444 1452 10.1111/j.1537-2995.2006.00914.x 1:CAS:528:DC%2BD28XpsFejtbw%3D 16934083 (Pubitemid 44117975)
34. RH Aster 1966 Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia J Clin Invest 45 645 657 10.1172/JCI105380 1:STN:280:DyaF287js1WrsA%3D%3D 5327481
35. M Peck-Radosavljevic M Wichlas J Zacherl G Stiegler P Stohlawetz M Fuchsjäger, et al. 2000 Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production Blood 95 795 801 1:CAS:528:DC%2BD3cXotV2isA%3D%3D 10648388
36. M Uemura Y Fujimura M Matsumoto H Ishizashi S Kato T Matsuyama, et al. 2008 Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis Thromb Haemost 99 1019 1029 1:CAS:528:DC%2BD1cXotVyjs7s%3D 18521503
37. PM Mannucci MT Canciani I Forza F Lussana A Lattuada E Rossi 2001 Changes in health and disease of the metalloproteinase that cleaves von Willebrand factor Blood 98 2730 2735 10.1182/blood.V98.9.2730 1:CAS:528: DC%2BD3MXotVegsb8%3D 11675345
38. HB Feys MT Canciani F Peyvandi H Deckmyn K Vanhoorelbeke PM Mannucci 2007 ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis Br J Haematol 138 534 540 10.1111/j.1365-2141.2007.06688.x 1:CAS:528:DC%2BD2sXhtVehs7%2FE 17608762 (Pubitemid 47063038)
39. T Lisman TN Bongers J Adelmeijer HL Janssen MP de Maat PG de Groot, et al. 2006 Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity Hepatology 44 53 61 10.1002/hep.21231 1:CAS:528:DC%2BD28XnsFWjt7w%3D 16799972 (Pubitemid 44049138)
40. AE Schorer CF Moldow ME Rick 1987 Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells Br J Haematol 67 193 197 10.1111/j.1365-2141.1987.tb02326.x 1:CAS:528:DyaL2sXmtlCms7w%3D 3499929
41. I Tornai J Hársfalvi Z Boda M Udvardy G Pfliegler K Rak 1993 Endothelium releases more von Willebrand factor and tissue-type plasminogen activator upon venous occlusion in patients with liver cirrhosis than in normals Haemostasis 23 58 64 1:STN:280:DyaK3s3jvFSgug%3D%3D 8477909
42. A Bernardo C Ball L Nolasco JF Moake J Dong 2004 Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow Blood 104 100 106 10.1182/blood-2004-01-0107 1:CAS:528:DC%2BD2cXlslWgs70%3D 15026315 (Pubitemid 38879844)
43. WJ Cao M Niiya XW Zheng DZ Shang XL Zheng 2008 Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells J Thromb Haemost 6 1233 1235 10.1111/j.1538-7836.2008.02989.x 1:CAS:528: DC%2BD1cXpt1ahtro%3D 18433458 (Pubitemid 351859136)
44. Y Kume H Ikeda M Inoue K Tejima T Tomiya T Nishikawa, et al. 2007 Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats FEBS Lett 581 1631 1634 10.1016/j.febslet.2007.03.029 1:CAS:528: DC%2BD2sXjvFGrt78%3D 17383642 (Pubitemid 46541684)
45. M Niiya M Uemura XW Zheng ES Pollak M Dockal F Scheiflinger, et al. 2006 Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo J Thromb Haemost 4 1063 1070 10.1111/j.1538-7836.2006.01893.x 1:CAS:528:DC%2BD28XltFajtbo%3D 16689760
46. M Yagita M Uemura T Nakamura A Kunitomi M Matsumoto Y Fujimura 2005 Development of ADAMTS-13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura J Hepatol 42 420 421 10.1016/j.jhep.2004.08.030 15710227 (Pubitemid 40254259)
47. M Matsumoto H Yagi H Wada Y Fujimura 2004 The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Semin Hematol 41 68 74 10.1053/j.seminhematol.2003.10.009 14727261 (Pubitemid 38057787)
48. P Tandon G Garcia-Tsao 2008 Bacterial infections, sepsis, and multiorgan failure in cirrhosis Semin Liver Dis 28 26 42 10.1055/s-2008-1040319 1:CAS:528:DC%2BD1cXjvFCju7c%3D 18293275 (Pubitemid 351326531)
49. M Sala A Forner M Varela J Bruix 2005 Prognostic prediction in patients with hepatocellular carcinoma Semin Liver Dis 25 171 180 10.1055/s-2005-871197 15918146 (Pubitemid 40781070)
50. M Lenzi S Bellentani G Saccoccio P Muratori F Masutti L Muratori, et al. 1999 Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort Gut 45 435 441 1:STN:280:DyaK1Mzns12isw%3D%3D 10446115
51. MY Hsieh CY Dai LP Lee JF Huang WC Tsai NJ Hou, et al. 2008 Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C J Clin Pathol 61 333 337 10.1136/jcp.2006.046276 1:CAS:528:DC%2BD1cXkt1yjtrs%3D 17545561 (Pubitemid 351354240)
52. BD Clifford D Donahue L Smith E Cable B Luttig M Manns, et al. 1995 High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C Hepatology 21 613 619 1:STN:280:DyaK2M7otVyitA%3D%3D 7533120
53. SW French NC Benson PS Sun 1984 Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats Hepatology 4 912 917 10.1002/hep.1840040521 1:CAS:528:DyaL2cXmt1CmtL0%3D 6479856
54. CS Lieber 2000 Alcoholic liver disease: new insights in pathogenesis lead to new treatments J Hepatol 32 1 Suppl 113 128 10.1016/S0168-8278(00)80420-1 1:CAS:528:DC%2BD3cXisFOns7c%3D 10728799
55. PS Haber R Warner D Seth MD Gorrell GW McCaughan 2003 Pathogenesis and management of alcoholic hepatitis Gastroenterol Hepatol 18 1332 1344 10.1046/j.1440-1746.2003.03217.x 1:CAS:528:DC%2BD2cXmvVeiug%3D%3D (Pubitemid 38045845)
56. H Fukui B Brauner JC Bode C Bode 1991 Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay J Hepatol 12 162 169 10.1016/0168-8278(91)90933-3 1:CAS:528:DyaK3MXktVaqu70%3D 2050995
57. M Uemura T Matsuyama M Ishikawa M Fujimoto H Kojima S Sakurai, et al. 2005 Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis Alcohol Clin Exp Res 29 12 Suppl 264S 271S 1:CAS:528:DC%2BD28Xms1ar 16385234
58. T Matsuyama M Uemura M Ishikawa M Matsumoto H Ishizashi S Kato, et al. 2007 Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis Alcohol Clin Exp Res 31 1 Suppl S27 S35 10.1111/j.1530-0277.2006.00283.x 17331163 (Pubitemid 46114912)
59. Ishikawa M, Uemura M, Matsuyama T, Matsumoto M, Ishizashi H, Kato S, et al. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia. Alcohol Clin Exp Res. 2008; Dec 16 [Epub ahead of print].
60. RA Reiter K Varadi PL Turecek B Jilma P Knöbl 2005 Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation Thromb Haemost 93 554 558 1:CAS:528:DC%2BD2MXivVGmsb4%3D 15735809
61. CL Bockmeyer RA Claus U Budde K Kentouche R Schneppenheim W Lösche, et al. 2008 Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor Haematologica 93 137 140 10.3324/haematol. 11677 1:CAS:528:DC%2BD1cXitVOhsLs%3D 18166799 (Pubitemid 351156164)
62. SI Bearman 1995 The syndrome of hepatic veno-occlusive disease after marrow transplantation Blood 85 3005 3020 1:CAS:528:DyaK2MXlvFehtb8%3D 7756636
63. GB McDonald P Sharma DE Matthews HM Shulman ED Thomas 1984 Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors Hepatology 4 116 122 10.1002/hep.1840040121 1:STN:280:DyaL2c7htVSisg%3D%3D 6363247
64. YD Park A Yoshioka K Kawa H Ishizashi H Yagi Y Yamamoto, et al. 2002 Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation Bone Marrow Transpl 29 789 794 10.1038/sj.bmt.1703544
65. M Matsumoto K Kawa M Uemura S Kato H Ishizashi A Isonishi, et al. 2007 Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels Bone Marrow Transpl 40 251 259 10.1038/sj.bmt.1705724 1:CAS:528:DC%2BD2sXnvFaqt7g%3D
66. HM Trimarchi LD Truong S Brennan JM Gonzalez WN Suki 1999 FK506-associated thrombotic microangiopathy: report of two cases and review of the literature Transplantation 67 539 544 10.1097/00007890-199902270-00009 1:CAS:528:DyaK1MXhvVKrtL4%3D 10071024
67. A Humar J Jessurun HL Sharp RW Gruessner 1998 Thrombotic microangiopathy after liver-small bowel transplant Clin Transpl 12 600 601 1:STN:280: DyaK1M%2FmslCntA%3D%3D
68. Y Nakazawa Y Hashikura K Urata T Ikegami M Terada H Yagi, et al. 2003 Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report Liver Transpl 9 1328 1333 10.1016/j.lts.2003.09.021 14625834 (Pubitemid 37536804)
69. C Ben Hamida JY Lauzet S Rezaiguia-Delclaux C Duvoux D Cherqui P Duvaldestin, et al. 2003 Effect of severe thrombocytopenia on patient outcome after liver transplantation Intens Care Med 29 756 762
70. FS Ramalho I Fernandez-Monteiro J Rosello-Catafau C Peralta 2006 Hepatic microcirculatory failure Acta Cir Bras 21 Suppl 1 48 53 17013514
71. S Ko E Okano H Kanehiro M Matsumoto H Ishizashi M Uemura, et al. 2006 Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases Liver Transpl 12 859 869 10.1002/lt.20733 16528712
72. J Basile A Busuttil PA Sheiner S Emre S Guy ME Schwartz, et al. 1999 Correlation between von Willebrand factor levels and early graft function in clinical liver transplantation Clin Transpl 13 25 31 10.1034/j.1399-0012.1999. t01-2-130104.x 1:STN:280:DyaK1M7otFCksA%3D%3D
73. K Kiuchi KJ Oldhafer HJ Schlitt B Nashan A Deiwick K Wonigeit, et al. 1998 Background and prognostic implications of perireperfusion tissue injuries in human liver transplants: a panel histochemical study Transplantation 66 737 747 10.1097/00007890-199809270-00008 1:STN:280:DyaK1cvkt1Orsg%3D%3D 9771837 (Pubitemid 28460108)
74. W Jassem DD Koo L Cerundolo M Rela ND Heaton SV Fuggle 2003 Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation Transplantation 76 1599 1603 10.1097/01.TP.0000100400.82135.DC 14702531 (Pubitemid 37549834)
75. Kobayashi T, Wada H, Usui M, Sakurai H, Matsumoto T, Nobori T, et al. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res. 2009; May 5 [Epub ahead of print].
76. ITA Pereboom J Adelmeijer Y van Leeuwen HGD Hendriks RJ Porte T Lisman 2009 Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation Am J Transpl 9 1189 1196 10.1111/j.1600-6143. 2009.02621.x 1:CAS:528:DC%2BD1MXmtVOnsrw%3D
77. SD Berkowitz J Dent J Roberts Y Fujimura EF Plow K Titani, et al. 1987 Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin J Clin Invest 79 524 525 10.1172/JCI112843 1:CAS:528:DyaL2sXhsFCisbw%3D 2433308